机译:血浆MIR-1290是一种新颖的和特异性生物标志物,用于早期诊断坏死性肠焦炎 - 生物标志物发现与前瞻性队列评价
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Stat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Imaging &
Intervent Radiol Shatin Hong Kong;
Chinese Univ Hong Kong Prince Wales Hosp Dept Pediat Shatin Hong Kong Peoples R China;
机译:血浆MIR-1290是一种新颖的和特异性生物标志物,用于早期诊断坏死性肠焦炎 - 生物标志物发现与前瞻性队列评价
机译:血浆糖化CD59(GCD59),一种新型生物标志物,用于诊断,管理和跟进妊娠期糖尿病(GDM)的妇女 - 前瞻性队列研究议定书
机译:抗胰腺抗体的重新发现及其在克罗恩病患者的预期临床队列中的预后价值评估:特定靶抗原的重要性[GP2和CUZD1]
机译:基于UHPLC-QTOF的代谢组科,用于使用大型跨国前瞻性队列的血清样品发现肝癌的病因生物标志物
机译:HIV特异性中和抗体(NAb)与ART治疗中断后的前瞻性评估队列临床进展的相关性
机译:血浆糖化CD59(GCD59)一种新型生物标志物用于诊断管理和跟进妊娠期糖尿病(GDM)的妇女 - 前瞻性队列研究议定书
机译:重新发现抗胰腺抗体并评估其在克罗恩病患者的预期临床队列中的预后价值:特定靶抗原GP2和CUZD1的重要性。